We are monitoring the impact of COVID-19 on Latin America Antacid Market Get in touch with us for detailed analysis Know More
Share on

Latin America Antacid Market Research Report - Segmented By Drug Class, Formulation Type, Distribution Channel & Country (Brazil, Mexico, Argentina, Chile & Rest of Latin America) - Industry Analysis on Size, Share, Trends & Growth Forecasts (2022 to 2027)

Published: January, 2022
ID: 2269
Pages: 145

Latin America Antacid Market Size & Growth (2022 to 2027):

The size of the Latin America Antacid Market was valued at USD 2.32 billion in 2022 and is estimated to be growing at a CAGR of 3.9% and worth USD 2.81 billion by 2027 during the forecast period 2022 to 2027.

Increased use of junk food, improper eating schedule, high spicy or oily food, sedentary lifestyle, bowel disorder, overconsumption of NSAIDS or other drugs, among others, are the factors responsible for the growing demand for antacids in the years to come. In addition, the increasing prevalence of GERD, obesity, and irritable bowel syndrome (IBS) results in the awareness of this disease, which is expected to boost the Latin American antacid market.

An article published in the International Foundation for Gastrointestinal Disorders provided information and support regarding the condition of antacids. Additionally, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) encourages patients with GERD-related symptoms to see their doctor. According to World Gastroenterology Organization, the prevalence of GERD is increasing worldwide and ranges from nearly 2.55% to 25.65% across the globe. Furthermore, according to the World Health Organization, more than $ 12 billion are spent on antacids worldwide each year.

In addition, consumption of citrus fruits and chocolate, coffee, carbonated drinks, etc., which increase the content of gastric HCl in the stomach, is advancing the prevalence of heartburn, affecting the market during the forecast period. Antacids to combat stomach acid are available today as an over counter drug in retail stores, pharmacies, and E-commerce websites, which helps in easy distribution and ease of convenience for the patients. Use of natural products to make antacid drug formulations like herbal extracts are becoming more popular to treat typical troubles such as heartburn.

However, the low awareness about gastrointestinal disorders in developing economies restricts antacids, limiting the market growth rate. In addition, self-medication of antacids without proper knowledge or guidance can lead to side effects such as nausea, vomiting, stomach ache, drug-drug interaction, dizziness, and disturbed digestion; this factor may challenge the market's growth.

This research report on the Latin American Antacid Market has been segmented and sub-segmented into the following categories.

By Drug Class: 

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-motility Agents

By Formulation Type: 

  • Tablet
  • Liquid
  • Powder

By Distribution Channel: 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Country: 

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Brazil antacid market is expected to be the most significant and fastest-growing regional segment during the forecast period due to high unmet clinical needs, prominence of online pharmacies, availability of effective treatment methods, the concentration of advanced pharmaceutical laboratories, and increase in disposable income and consumer awareness of the availability of these products.

The Argentina antacid market is estimated to be the second growing regional market. It can be attributed to the increased prevalence of digestive disorders, improving health infrastructure, increasing investments by market players, and consumer awareness of antacid products in the region. According to the CDC, the number of emergency department visits with digestive system diseases as the primary diagnosis was approximately 22 million. Moreover, it is likely to remain high in the years to come, given the availability of junk food, which encourages more people towards unhealthy eating habits and obesity.

The Mexico antacid market will be a good market for antacids, estimated to account for 20% of the total market share by 2028. Given the high penetration of pharmaceutical manufacturing companies in the region, relaxation of regulations for drug distribution, and the popularity of the online shopping culture, players operating in the antacids market in this region will have good sales in the years to come.

Regional markets in Peru, Columbia, and Puerto Rico will contribute to revenue generation owing to the widespread availability of antacids in retail pharmacies and public awareness.

KEY MARKET PLAYERS

Some of the leading companies dominating in the Latin American Antacid Market profiled in this report are Sun Pharma, Digene (Abbott India), Pudin Hara (Dabur), Gelusil (Pfizer), GlaxoSmithKline plc, Abbott Laboratories, Pfizer, Inc., 

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Introduction           

                                5.1.2 Proton Pump Inhibitors     

                                5.1.3 H2 Antagonist        

                                5.1.4 Pro-motility agents              

                                5.1.5 Acid Neutralizers  

                                5.1.6 Y-o-Y Growth Analysis, By Drug Class          

                                5.1.7 Market Attractiveness Analysis, Drug Class              

                                5.1.8 Market Share Analysis, By Drug Class         

                5.2 Formulation Type                    

                                5.2.1 Introduction           

                                5.2.2 Tablet        

                                5.2.3 Liquid        

                                5.2.4 Powder    

                                5.2.5 Y-o-Y Growth Analysis, By Formulation Type            

                                5.2.6 Market Attractiveness Analysis, By Formulation Type          

                                5.2.7 Market Share Analysis, By Formulation Type           

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Retail pharmacies 

                                5.3.4 Other        

                                5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.6  Market Attractiveness Analysis, By Distribution Channel   

                                5.3.7 Market Share Analysis, By Distribution Channel      

                5.4 Disease Indications  5.4.1 Introduction           

                                5.4.2 Cancer      

                                5.4.3 CardiovascularDisorders    

                                5.4.4 Neurological Disorders       

                                5.4.5 Immunological Disorders  

                                5.4.6 Other Diseases      

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications         

                                5.4.8  Market Attractiveness Analysis, By Disease Indications      

                                5.4.9  Market Share Analysis, By Disease Indications       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Class

                                                6.1.3.3 By Formulation Type

                                                6.1.3.4 By Distribution Channel

                                6.1.4 Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Class

                                                6.1.4.3 By Formulation Type

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Class

                                                6.1.5.3 By Formulation Type

                                                6.1.5.4 By Distribution Channel

                6.2 Latin America                             

                                6.2.1 Introduction           

                                6.2.2 Brazil          

                                6.2.3 Argentina

                                6.2.4 Mexico     

                                6.2.5 Rest of Latin America          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Glaxo Smith                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Abbott Laboratories               

                8.3 Pfizer Inc                     

                8.4 Sun Pharmaceuticals                              

                8.5 Consumer Health                     

                8.6 Dabur                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                

  1. Latin America Antacid Market, By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  3. Latin America Proton Pump Inhibitors Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America H2 Antagonist Market, By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Acid Neutralizers Market, By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Pro-Motility Agents Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  8. Latin America Tablet Market, By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Liquid Market, By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Powder Market, By Region, From 2022 - 2027 (USD Billion)
  11. Latin America Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)
  12. Latin America Hospital Pharmacies Market, By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Retail Pharmacies Market, By Region, From 2022 - 2027 (USD Billion)
  14. Latin America Others Market, By Region, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample